Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
2010 ◽
Vol 339
(5)
◽
pp. 433-439
◽
2013 ◽
Vol 35
(8)
◽
pp. 563-569
◽
2010 ◽
Vol 32
(1)
◽
pp. 21-28
◽
2017 ◽
Vol 19
(10)
◽
pp. 983-989
◽
2012 ◽
Vol 40
(1)
◽
pp. 1-9
◽
Keyword(s):
2012 ◽
Vol 59
(6)
◽
pp. 1132-1138
◽
2015 ◽
Vol 18
(7)
◽
pp. 672-678
◽